A nimal and human studies indicate that estrogens are protective against coronary atherosclerosis. Multiple potential mechanisms may be involved, such as favorable effects on lipids, 1 fibrinolysis, 2 coronary flow, 3, 4 and myocardial contractility. 5 Although recent evidence suggests the existence of both estrogen and androgen receptors in VSMCs and endothelial cells, 6 the precise biological role of sex hormones in either cell type is currently incompletely understood. There are well-known examples of estrogenic and/or androgenic control of cell growth and proliferation in classic target organs for sex hormone action. Because endothelial repair and VSMC proliferation have defined pathophysiological roles in vascular injury and atherogenesis, the potential modulation of such processes by sex hormones is of obvious interest. In several tissues, the effects of estrogen, including growth modulation, are linked to the induction of CK activity, and this has been used as a general genomic response marker for gonadal steroids. CK is involved in cellular energy buffering and is closely related to changes in cell replication rate in various cell types. [7] [8] [9] The present study was undertaken to explore the effects of estrogens and androgens on DNA synthesis and CK activity in human endothelial cells and VSMCs. The results are consistent with complex, dose-dependent, and cell-specific in vitro effects of both E 2 and DHT on proliferative activity in the vascular wall.
Methods
Reagents E 2 , DHT, progesterone, IGF-1, and PDGF were purchased from Sigma Chemical Co. TAM was the gift of Dr A. Wakeling (Xeneca Ltd, Macclefield, UK). TMI was obtained from Dr A. Beigon (Pharmos Ltd, Rehovot, Israel). RAL was the gift of Dr B. Fournier (Ciba-Geigy Ltd, Basel, Switzerland). The antiidiotypic antiestrogen antibody 1D 5 and its F(abЈ) 2 and FabЈ fragments were prepared by us, as previously described. 10 The monoclonal antiestradiol antibody E15 was raised in mice by us and characterized as previously described. 11 The FabЈ monomer of E15 was prepared and analyzed as reported elsewhere.
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Cell Cultures
Umbilical Artery Smooth Muscle Cells
The use of human umbilical cords was approved by our institution's human subject committee. Umbilical VSMCs were prepared as previously described with minor modifications. 12 In brief, umbilical cords were collected shortly after delivery, and arteries were dissected, cleaned of blood and adventitia, and cut into tiny slices (1 to 3 mm). The segments were kept in culture in Medium 199 containing 20% fetal calf serum, glutamine, and antibiotics. Cell migration was detected within 5 to 7 days. Cells were fed twice a week and, on confluence, trypsinized and transferred to 24-well dishes. Cells were used only at passages 1 to 3 when expression of smooth muscle actin was clearly demonstrable.
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Endothelial Cells
E304 cells, an endothelial cell line derived from a human umbilical vein, were obtained from American Type Culture Collection and grown in Medium 199 containing 10% fetal calf serum, glutamine, and antibiotics.
Detection of Estrogen Receptors
Cultured cells were washed with 0.5 mL cold methanol, fixed by incubating the cells with 1 mL methanol at Ϫ20°c, and then washed twice with 1 mL of cold PBS for 5 minutes at 0°C. The cells were then incubated with 250 L FITC-labeled monoclonal antiidiotypic antiestrogen antibody 1D 5 directed against the steroid binding domain of the estrogen receptor for 1 hour at 0°C in the dark. After the incubation, cells were washed twice with cold PBS for 5 minutes. The labeled receptors were visualized by fluorescence microscopy. Control cultures were incubated in the same way with FITC-labeled IgG.
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Assessment of DNA Synthesis
Cells were grown until subconfluence and then treated with various hormones or agents as indicated. Twenty-two hours later, [ 3 H]thymidine (thymidine [methyl-3 H], 50 Ci/mmol, 1 mCi/mL, ICN Pharmaceutical Inc) was added for 2 hours. Cells were then treated with 10% ice-cold trichloroacetic acid (TCA) for 5 minutes and washed twice with 5% TCA and then with cold ethanol. The cellular layer was dissolved in 0.3 mL of 0.3N NaOH, the samples were collected, and [
3 H]thymidine incorporation into DNA was determined.
9
CK Extraction and Assay
Cells were treated for 4 hours with the various hormones and agents as specified and were then scraped off the culture dishes and homogenized by freezing and thawing three times in an extraction buffer as previously described. 9 Supernatant extracts were obtained by centrifugation of homogenates at 14000g for 5 minutes at 4°C in an Eppendorf microcentrifuge. CK was determined by a coupled spectrophotometric assay (Sigma) as described previously. 8 Protein was determined by Coomassie blue dye binding using bovine serum albumin as the standard. 14 
Statistical Analysis
Comparisons between the control and various treatments were made by ANOVA.
Results
Estrogen Receptors
As shown in Figure 1 , incubation of VSMCs and E304 cells with the FITC-labeled 1D 5 , an antibody that binds to the estrogen receptor, resulted in nuclear labeling (Figure 1) , whereas control cells incubated with FITC-labeled IgG showed no staining. In most cells, labeling was entirely confined to the nucleus. However, occasional cytoplasmic (but not membranous) staining was also seen.
Modulation of DNA Synthesis by Gonadal Steroids
Endothelial Cells
Both E 2 (0.3 to 300 nmol/L) and DHT (3 to 3000 nmol/L) induced dose-dependent increases in [ 3 H]thymidine incorporation into DNA ( Figure 2 ). As shown, cells were somewhat more sensitive to E 2 than to DHT (one order of magnitude). In contrast, progesterone (6 mol/L) had no effect on DNA synthesis.
VSMCs E 2 and DHT had a biphasic effect on DNA synthesis. At a low concentration of E 2 (0.3 nmol/L), [ 3 H]thymidine incorporation was stimulated, whereas higher concentrations of E 2 (Ն30 nmol/L) led to inhibition of DNA synthesis ( Figure 2 ). Similar dose-related effects were seen with DHT, ie, stimulation with a low concentration (3 nmol/L) and inhibition with high concentrations (Ն300 nmol/L). As with endothelial cells, [ 3 H]thymidine incorporation into DNA was unaffected by progesterone.
Regardless of the variable effect on DNA synthesis, E 2 and DHT (but not progesterone) dose-dependently stimulated the specific activity of CK in both cell types ( Figure 3 ).
Interaction Between Gonadal Steroids and PDGF or IGF-1
Endothelial Cells PDGF or IGF-1 alone, as well as the combination of either growth factor with E 2 or DHT, increased [ 3 H]thymidine incorporation in endothelial cells (Figure 4 ). At the low concentrations of gonadal steroids, no synergistic or additive effect was seen between E 2 or DHT and PDGF or IGF-1. However, [ 3 H]thymidine incorporation was significantly increased (PϽ0.05) when E304 cells were exposed to the higher concentration of E 2 or DHT in the presence of either PDGF or IGF-1 compared with the effects of PDGF or IGF-1 alone (Figures 4 and 5 ). E 2 increased CK activity (0.3 nmol/L: 30Ϯ8%; 30 nmol/L: 90Ϯ11%). CK activity was likewise stimulated by PDGF (1 ng/mL: 30Ϯ5%; 5 ng/mL: 52Ϯ11%), and IGF-1 (12.5 ng/mL: 43Ϯ13%; 25 ng/mL: 52Ϯ3%). In the presence of E 2 (30 nmol/L), both PDGF (5 ng/mL) and IGF-1 (25 ng/mL) elicited even larger increments in CK (107Ϯ10% and 93Ϯ2%, respectively). DHT also increased CK activity (at 3 nmol/L: 38Ϯ5%; at 300 nmol/L: 56Ϯ4%). However, the effect of DHT (300 nmol/L) was not modified in the presence of PDGF (1 or 5 ng/mL, 53Ϯ9% and 70Ϯ11%, respectively).
Selected Abbreviations and Acronyms
CK ϭ creatine kinase DHT ϭ dihydrotestosterone E 2 ϭ 17␤-estradiol IGF-1 ϭ insulin-like growth factor-1 PDGF ϭ platelet-derived growth factor RAL ϭ raloxifene TAM ϭ tamoxifen TMI ϭ tamoxifen methiodide VSMC ϭ vascular smooth muscle cell
VSMCs
The separate effects of E 2 (0.3 and 30 nmol/L), PDGF (1 and 5 ng/mL), or IGF-1 (12.5 and 25 ng/mL) on DNA synthesis in VSMCs are shown in Figure 4 . Stimulation of [
3 H]thymidine incorporation was induced by either of these growth factors and by the low dose of E 2 . However, when E 2 (30 nmol/L) was present, the stimulatory effects of IGF-1 and PDGF were entirely inhibited. Furthermore, growth factor-induced DNA synthesis was suppressed to below basal levels. CK-specific activity was increased by E 2 (0.3 nmol/L: 20Ϯ4%; 30 nmol/L: 74Ϯ13%), IGF-1 (12.5 ng/mL: 25Ϯ7%; 25 ng/mL: 72Ϯ9%), or PDGF (1 ng/mL: 44Ϯ10%; 5 ng/mL: 133Ϯ29%), as well as by the combinations of E 2 (30 nmol/L) with PDGF (43Ϯ13% and 52Ϯ3% at the two concentrations applied) or IGF-1 (84Ϯ7% and 107Ϯ10% at the two concentrations applied). DHT (at 300 nmol/L but not at 3 nmol/L) inhibited PDGF-dependent DNA synthesis ( Figure 5 ). In contrast, CK activity was stimulated by DHT alone (3 nmol/L: 54Ϯ11%; 300 nmol/L: 83Ϯ9%), PDGF alone (1 ng/mL: 41Ϯ12%; 5 ng/mL: 48Ϯ9%), or by their combination (300 nmol/L DHTϩPDGF: 68Ϯ9% and 122Ϯ19%, respectively), although no additive effect was observed.
Effect of Antiestrogens and Flutamide on DNA Synthesis
Endothelial Cells
In E304 cells, both TAM (30 nmol/L and 3 mol/L) alone or RAL (30 nmol/L and 3 mol/L) alone stimulated DNA synthesis, whereas TMI was ineffective ( Figure 6 ). When E 2 was also added to antiestrogen-containing dishes (TAM, RAL, or TMI at 100-fold excess), this agonist-like effect of antiestrogens on DNA synthesis was not discernible ( Figure  6 ). Whereas the antiandrogen flutamide was ineffective by itself, it inhibited the DHT-dependent increase in DNA synthesis ( Figure 7) .
VSMCs
In VSMCs, the antiestrogen TMI had no effect, whereas both TAM and RAL mimicked the effect of E 2 , exhibiting a stimulatory effect at a low dose (30 nmol/L) and an inhibitory effect at a higher dose (3 mol/L). Notably, in the presence of a low concentration of E 2 , the antiestrogens (at 100-fold excess) did not antagonize the E 2 -stimulated DNA synthesis. Likewise, the antiestrogens had no effect on the inhibition of DNA synthesis exerted by a high concentration of estradiol ( Figure 6 ). In both cell types, TAM and RAL (but not TMI) enhanced CK activity. In E304, TAM (3 mol/L) increased CK by 81Ϯ13%, RAL by 66Ϯ13%, and TMI by 1Ϯ8%. Similarly, in VSMCs, the same estrogen antagonists (3 mol/L) stimulated CK activity (TAM: 85Ϯ4%; RAL: 74Ϯ11%; and TMI: Ϫ2Ϯ5%). These antagonist-induced increases in CK were not apparent in the presence of E 2 . Flutamide (10 nmol/L) had no significant effect on DNA synthesis. However, flutamide blocked both the increase in DNA synthesis induced by a low concentration of DHT and the inhibition of 
Effect of Antiidiotypic Antiestrogen Antibody 1D 5 and Monoclonal Antiestrogen Antibody E15
The antiidiotypic antibody 1D 5 (8.33 nmol/L), which has estrogen-mimetic activity, elicited a stimulatory effect on DNA synthesis in E304 cells and an inhibitory effect in VSMCs (Figure 8 ). In contrast, the F(abЈ) 2 fragment of this antibody, which was inactive by itself, inhibited the effect of E 2 and 1D 5 in both cell types (Figure 8 ). In these cells, E 2 (30 nmol/L) caused a 75Ϯ13% increase in CK activity, whereas 1D 5 (8.33 nmol/L) increased CK by 49Ϯ6% (compared with a nonsignificant increment of 8Ϯ9% observed with IgG). Although the F(abЈ) 2 fragment of 1D 5 alone did not modify CK activity (8Ϯ12%), it blocked the E 2 -and 1D 5 -induced increments in CK (13Ϯ14% and 15Ϯ6%, respectively).
The monoclonal, high-affinity antiestradiol antibody E15 (previously found to enhance E 2 activity 11 ) had no effect on DNA synthesis (Figure 9 ) or CK-specific activity in either cell type. However, its (FabЈ) proteolytic fragment, which was likewise inactive on its own, reversed E 2 -dependent suppression of [ 3 H]thymidine incorporation in VSMCs and E 2 -induced stimulation of DNA synthesis in E304 cells (Figure 9 ). CK-specific activity was enhanced by 30 nmol/L of E 2 (76Ϯ12%). E15 (2.5 g/mL) had no effect on basal (Ϫ11Ϯ13%) or E 2 -stimulated CK activity (68Ϯ12%). Whereas its FabЈ fragment (2.5 g/mL) likewise had no independent effect (14Ϯ7%), it entirely blocked the effect of E 2 (2Ϯ4%).
Discussion
In the present report, we focus on one aspect of the interaction of gonadal steroids with the vasculature, ie, the effects of sex hormones and their antagonists on DNA synthesis in endothelial and smooth muscle cells derived from human umbilical vessels. Previous investigations indicated that the myointimal proliferative response to balloon injury in the rat carotid artery was inhibited by estrogens but not by androgens, thus suggesting a differential effect on the response to injury. 14, 15 The effects of estradiol on DNA synthesis in our study are consistent with the concept that estrogen might influence vascular wall remodeling by inhibition of VSMC proliferation and increasing the rate of reendothelialization. The inhibition of DNA synthesis in VSMCs by higher E 2 concentrations is in accordance with previous reports in porcine and human cells. 16, 17 The specificity of estradiol's interaction with VSMCs and E304 cells in the present work is supported by several findings. First, both cell types contained nuclear estradiol receptors. Second, under various experimental conditions the combined effects of estradiol and antiestrogens were consistent with competitive inhibition. For example, both estradiol and TAM (or RAL) increased DNA synthesis, but in accordance with observations in other estrogen responsive tissues, 18 this effect was not . In other incubates, cells were exposed to both E 2 (30 nmol/L) and either E15 (2.5 g/mL) or (FabЈ) (2.5 g/mL). DNA synthesis is expressed as described in Figure 2 . C indicates control.
apparent in the presence of both the agonist and the antagonist. Similarly, both estradiol and estrogen antagonists (TAM and RAL) increased CK activity in E304 cells and VSMCs, but these actions did not persist when estradiol and these antagonists were added simultaneously to the same cultures. Third, antiidiotypic antiestrogen antibodies shown in previous studies to possess estrogen-mimetic activity 19 elicited a stimulatory effect on DNA synthesis and CK activity in E304 cells and inhibited [ 3 H]thymidine incorporation in VSMCs, thus exerting the same cellspecific effects induced by estradiol itself. Fourth, the F(abЈ) 2 fragment of the antiidiotypic antiestrogen antibody 1D 5 inhibited the effects of estradiol on DNA synthesis in E304 cells as well as in VSMCs. Finally, the FabЈ proteolytic fragment of the high-affinity antiestradiol antibody E15 blocked estradiol-dependent effects on DNA synthesis and CK-specific activity in both E304 cells and VSMCs as observed in other cell types.
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Although we did not establish which type of estrogen receptor is involved, recent observations indicating that estradiol inhibits VSMC proliferation after balloon injury in transgenic mice lacking the ␣ form of the estrogen receptor 20 raise the possibility that at least some of the effects reported herein are related to the ␤-type receptor.
Our results indicate that overall, estradiol induces opposing effects on DNA synthesis in endothelial cells and VSMCs. However, in VSMCs, estradiol acts in a bimodal fashion, enhancing [ 3 H]thymidine incorporation at very low concentrations (prepubertal and postmenopausal range) while inhibiting DNA synthesis at high concentrations such as those attained during the ovulatory phase. Whether this bimodal dose dependency is unique to cells derived from umbilical vessels or rather represents a general phenomenon in human arterial tissue must be addressed in further studies. Of note is the finding that regardless of whether DNA synthesis was stimulated or inhibited, CK activity was stimulated in a dose-dependent fashion in both cell types, thus suggesting energy-requiring responses.
The interaction between estradiol and two different growth factors acting in the vasculature, PDGF and IGF-1, further underscores the differential effect of estrogen in endothelial cells and VSMCs. Estradiol entirely blocked the increase in [ 3 H]thymidine incorporation into DNA induced by PDGF and IGF-1, whereas in E304 cells these effects were further enhanced in the presence of estradiol. Because IGF-1 and PDGF are likely involved in the proliferative response of VSMCs to various stimuli such as angiotensin II, endothelial injury, and platelet aggregation, the potent antiproliferative effect of estradiol, reducing PDGF-and IGF-1-dependent DNA synthesis to below basal levels, may have considerable pathophysiological significance. Although some antiestrogens may confer cardiovascular protection, 21 little is known with respect to their mode of action in the vasculature. The finding that TAM and RAL indeed mimic the effect of estradiol on DNA synthesis in both endothelial cells and VSMCs suggests one potential mechanism by which their vascular effect might take place. Notably, however, not all estrogen-mimetic effects of antiestrogens are necessarily conserved in the presence of estradiol, as is exemplified by the loss of stimulation of [ 3 H]thymidine incorporation when both agonists and antagonists are present.
To our knowledge, this is the first report of an androgenic inhibition of DNA synthesis in human VSMCs and stimulation in endothelial cells. The antiandrogen flutamide effectively blocked these effects while exerting no effect on its own. The observation that DHT modulates DNA synthesis in both VSMCs and endothelial cells in a manner that closely resembles the action of estrogen, albeit at a higher concentration range, was somewhat unexpected. Given that testosterone concentrations in vivo are 10 to 100 times higher than those of estradiol, DHT modulation of DNA synthesis in this study is operative at physiological levels. However, attempts to discern the effects of estrogens and androgens in the vasculature in vivo are inevitably complicated by the fact that androgen-free or estrogen-free environments practically do not exist in adult human subjects.
In summary, estradiol and DHT modulate DNA synthesis in human vascular cells in a parallel fashion. Their effects in VSMCs are bimodal, inducing stimulation at low concentrations and inhibition at high concentrations. In contrast, [ 3 H]thymidine incorporation into DNA by cells of endothelial origin is positively influenced by both estradiol and DHT. Antiestrogens alone exert estrogen-mimetic effects, but their mode of action is more complex in the presence of estradiol. The interactions between estrogens, androgens, PDGF, and IGF-1 may be important for vascular wall repair and remodeling.
